SCHEMBL3560979

SCHEMBL3560979

CC(=O)n1c(C)c(OCCN(C)C)c2cc(Cl)cc(Cl)c21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALDH1A1 P00352 4/20 0.46
MAPT P10636 1/20 0.41
AHR P35869 1/20 0.39
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
HPGD P15428 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
CHRM2 P08172 1/20 0.34
ADRA2A P08913 1/20 0.34
CHRM1 P11229 1/20 0.34
ADRA2B P18089 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14953563 0.88 KDM4E (0.42) KDM4ETDP1ALDH1A1MAPTGAA
SCHEMBL3556742 0.84 KDM4E (0.43) KDM4ETDP1ALDH1A1MAPTGAA
SCHEMBL6820272 0.84 KDM4E (0.46) KDM4ETDP1ALDH1A1GAAMAPK1
SCHEMBL6821026 0.81 KDM4E (0.41) KDM4ETDP1ALDH1A1MAPT
SCHEMBL3553237 0.81 KDM4E (0.44) KDM4ETDP1ALDH1A1GAAMAPK1
SCHEMBL3562851 0.80 KDM4E (0.43) KDM4ETDP1ALDH1A1MAPTHRH3
SCHEMBL3560116 0.80 KDM4E (0.43) KDM4ETDP1ALDH1A1MAPTGAA
SCHEMBL3557557 0.78 HTR6 (0.40) KDM4ETDP1ALDH1A1MAPTHPGD
SCHEMBL3557974 0.77 KDM4E (0.38) KDM4ETDP1ALDH1A1MAPT
SCHEMBL3562439 0.77 HTR6 (0.45) KDM4ETDP1ALDH1A1MAPTHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT KDM4E 3751/4885TDP1 2407/4885ALDH1A1 1943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.